QDEL · Nasdaq · CIK 0001906324

QuidelOrtho Corp

QuidelOrtho Corp’s most recent SEC filing in our snapshot is a Form 4 filed on Oct 19, 2026. In fiscal 2025 (year ended Dec 28, 2025) it reported revenue of $2.7B and net income of -$1.1B, according to its XBRL data on EDGAR. Its EDGAR record lists 60 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$2.7B
Net income, FY2025
-$1.1B
Form 4 filings on record, past 12 months
60

Company overview

Legal name (as filed)
QuidelOrtho Corp
Ticker
QDEL
SEC Central Index Key (CIK)
0001906324
Business address
SAN DIEGO, CA
State or country of incorporation
—
Fiscal year ends
January 1
SEC filer category
Large accelerated filer
Position in SEC ticker list
#2477 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from QuidelOrtho Corp’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$1.7BFY2022$3.3BFY2023$3.0BFY2023$2.8BFY2024$2.7BFY2025
Net income
$704.2MFY2022$548.7MFY2023-$10.1MFY2023-$2.1BFY2024-$1.1BFY2025
QDEL annual results
ItemFY2022
ended Jan 2, 2022		FY2023
ended Jan 1, 2023		FY2023
ended Dec 31, 2023		FY2024
ended Dec 29, 2024		FY2025
ended Dec 28, 2025
Revenue$1.7B$3.3B$3.0B$2.8B$2.7B
Net income$704.2M$548.7M-$10.1M-$2.1B-$1.1B
Diluted EPS$16.43$9.56-$0.15-$30.54-$16.69
Total assets$2.4B$8.9B$8.6B$6.4B$5.8B
Cash and equivalents$802.8M$292.9M$118.9M$98.3M$169.8M

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

QDEL latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 19, 202610-KAnnual report· period Dec 28, 2025Document · Index
Aug 7, 202610-QQuarterly report· period Jun 28, 2026Document · Index
Sep 23, 20268-KMaterial agreement· period Sep 23, 2026Document · Index
Apr 27, 2026DEF 14ADefinitive proxy statement· period Jun 16, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about QuidelOrtho Corp, by form type:

4 ×27SCHEDULE 13G/A ×48-K ×4SCHEDULE 13G ×23 ×110-Q ×1S-8 ×1
QDEL recent filings
FiledFormWhat it isOriginal
Oct 19, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 7, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Sep 23, 20268-KMaterial agreement· period Sep 23, 2026Document · Index
Sep 17, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 15, 2026Document · Index
Aug 18, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 15, 2026Document · Index
Aug 14, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 14, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 13, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 7, 202610-QQuarterly report· period Jun 28, 2026Document · Index
Aug 6, 20268-KResults of operations· period Aug 6, 2026Document · Index
Aug 5, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jul 16, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 15, 2026Document · Index
Jul 15, 20263Initial statement of beneficial ownership· period Jul 6, 2026Document · Index
Jul 13, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Jul 8, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jul 2, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026Document · Index
Jun 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 25, 2026Document · Index
Jun 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 25, 2026Document · Index
Jun 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 25, 2026Document · Index
Jun 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 25, 2026Document · Index
Jun 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 25, 2026Document · Index
Jun 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 25, 2026Document · Index
Jun 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 25, 2026Document · Index
Jun 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 25, 2026Document · Index
Jun 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 25, 2026Document · Index
Jun 23, 20268-KDirector or officer change; Regulation FD disclosure· period Jun 22, 2026Document · Index
Jun 16, 20268-KShareholder vote results· period Jun 16, 2026Document · Index
Jun 9, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 6, 2026Document · Index
Jun 9, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 6, 2026Document · Index
Jun 9, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 6, 2026Document · Index
Jun 9, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 6, 2026Document · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index

Insider filing activity

60 Form 4 filings appear in QuidelOrtho Corp’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in In Vitro & In Vivo Diagnostic Substances

All 8 companies in In Vitro & In Vivo Diagnostic Substances· Companies headquartered in California

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001906324 and XBRL company facts. QuidelOrtho Corp on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.